HOME

Genotypes

 

   
  Located on Page Two :
 

 

Information on Treatment According to Genotype

2008

2007

2006

2005 Index  Genotype Research

2004 Thru 2001 Index of all Genotype Research 


Located On This Page :

What is a Genotype

 (Covers all Genotypes also a Map of where Genotypes originated)

 

 

 

Genotype

What does the term genotype mean?
Genotype refers to the genetic make-up of an organism or a virus. There are at least six distinct HCV genotypes identified. Genotype 1 is the most common genotype seen in the U.S. HCV is an RNA virus related to the flavivirus family.  RNA viruses are genetically less stable than DNA viruses and are prone to mutate during replication.  It’s a common misconception that hepatitis C is just one virus, but in reality (as a result of mutation over hundreds of years), it’s a group of very closely related strains.  They are similar enough to be called HCV, but based on genetic differences, they can be classified into distinct groups called genotypes.

Is it necessary to do genotyping when managing a person with chronic hepatitis C?
No. Although persons with genotype 1 respond less often to treatment, genotype should not be a deciding factor on whether or not to treat. With newer therapies, however, treatment regimens might differ on the basis of genotypes.

Why do most persons remain infected?
Persons infected with HCV mount an antibody response to parts of the virus, but changes in the virus during infection result in changes that are not recognized by preexisting antibodies. This appears to be how the virus establishes and maintains long-lasting infection.

Can persons become infected with different genotypes?
Yes. Because of the ineffective immune response described above, prior infection does not protect against reinfection with the same or different genotypes of the virus. For the same reason, there is no effective pre- or postexposure prophylaxis (i.e, immune globulin) available.

What is a Quasispecies?
As the virus continues to replicate in each person, there is the potential for quasispecies to form.  Quasispecies are very closely related mutations of the original virus they were infected with.  Over time the diversity of quasispecies increases and may affect response to treatment.

Do Genotypes Play a role in Disease Progression?
This is still a controversial area.  Many studies have shown genotype 1, especially type 1b to be associated with more advanced liver disease, however these patients are generally older and have a longer duration of infection.  Poynard et al assessed factors associated with fibrosis progression in a large study involving 2,235 patients.  No link was found between genotype and fibrosis progression.

What about Genotypes and Treatment?
Research has shown people with genotypes 2 or 3 have a higher sustained response rate (60-70%) to combination therapy than genotype 1 (20-30%).   However other factors such as stage of fibrosis or cirrhosis, viral load, age, gender, duration of disease and excessive alcohol consumption also influence response to therapy.

Furthermore the duration of treatment is also influenced by genotype.  Previously untreated patients with genotype 1 double their chance of a sustained response when treated for 12 months instead of 6 months.  Conversely 12 months  treatment for patients with genotypes 2 or 3 does not improve response rates over 6 months treatment.

Can Genotypes be used in studying the Modes of Transmission?
Genotyping has been used to study the ways hepatitis C is transmitted.  It has been used to identify the source of infection in cases of patient-to-patient transmission and is also useful in the study of other modes eg. vertical (mother to baby), sexual transmission and needle stick injury.

 

  Prevalence of HCV Genotypes in US Population
 

By Brian Boyle, MD

In order to better characterize genotypic variants, which may be important for defining more effective treatment options for chronic hepatitis C virus (HCV) infection, greater than 81,000 patient results were analyzed at one laboratory in the U.S.

The investigators found that the most prevalent genotypes in the U.S. were 1 (57,653, 71.0%), 2 (11,588, 14.3%), and 3 (9,416, 11.6%), followed by a less common type 4 (1,375, 1.7%). Each of the remaining types represented less than 1% of the population; however, unlike other rare genotypes, the prevalence of group 6 was quite significant (1,197, 1.5%) and when the overall prevalence of this genotype in the U.S. is calculated this would mean that up to 60,000 HCV-infected individuals have this genotype.

Finally, the investigators found that the prevalence of each genotype in the population was relatively stable over the time period 1999 to 2002.

The authors conclude, “In the United States up to 4 million people are infected with HCV. If the results of our study are applied to this number, group 6 genotypes may represent. Therefore, there is a compelling need to consider the less common genotypes, particularly those of group 6, for inclusion into future clinical studies.”

9-17-03

Reference
TE Schutzbank and others. HCV Population Study in the U.S.: an Incentive for Further Clinical Trials. Abstract: V-775. Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. September 14-17, 2003. Chicago, IL.

 

What is a Genotype? (How many different types are there?)   
Our special thanks to Sharon Nicholson

 

Most of us learn about Hepatitis C as one disease, however in actuality it's really several different strains of a virus. They are all similar enough to be called hepatitis C virus, yet different enough to be classified into subgroups.

HCV GENOTYPES are broken down into sub-types, some of which include: 1a, 1b, 1c 2a, 2b, 2c 3a, 3b 4a, 4b, 4c, 4d, 4e 5a 6a 7a, 7b 8a, 8b 9a 10a 11a

********************************************************

               HCV genotype

Genotype Geography Patterns:

It is believed that the hepatitis C virus has evolved over a period of several thousand years. This would explain the current general global patterns of genotypes and subtypes:

1a - mostly found in North & South America; also common in Australia

1b - mostly found in Europe and Asia.

2a - is the most common genotype 2 in Japan and China.

2b - is the most common genotype 2 in the US and Northern Europe.

2c - the most common genotype 2 in Western and Southern Europe.

3a - highly prevalent here in Australia (40% of cases) and South Asia.

4a - highly prevalent in Egypt

4c - highly prevalent in Central Africa

5a - highly prevalent only in South Africa

6a - restricted to Hong Kong, Macau and Vietnam

7a and 7b - common in Thailand

8a, 8b & 9a - prevalent in Vietnam

10a & 11a - found in Indonesia

*************************************************************

One way to understand the terminology of HCV like ‘genotypes’ and ‘subtypes’ is to compare them to things that we can more readily relate to.

Example:

Imagine that Viruses are like canines. Dogs have evolved into different types, just like the thousands of different viruses. Imagine that all terriers are the hepatitis C viruses, Now each type of terrier is representing different genotypes of Hepatitis C.

All terriers are still dogs, but the Australian Terrier is different from the Fox Terrier, just as the Bull Terrier is different from the Border Terrier.

You could take one major terrier type and imagine these as being one of HCV’s main types (genotypes). Like the Schnauzer. There are different types of Schnauzers like the Miniature and the Standard. That represents the different subgroups within each genotype.

Now scientists predict that people who have hepatitis C, have billions of actual viruses circulating within their body. Although there may be one or two predominant sub-types, the infection as a whole is not a single entity and is composed of many different quasispecies.

It’s believed that of the estimated 160,000 Australians with HCV, approx. 35% have subtype ‘1a’, 15% have ‘1b’, 7% have ‘2’, 35% have ‘3’ (mostly being 3a). The remaining people would have other genotypes.

Genotype and Treatment

Current scientific belief is that factors such as which genotype patients carry, their duration of a HCV infection, their HCV viral load, their age, and grade of liver inflammation or stage of fibrosis may play an important role in determining response to interferon treatment. Recent studies have suggested that a person’s HCV subtype is the key-factor that influences their possible response to interferon, or interferon-ribavirin combination treatment.

It is very important to find out which genotype you carry.

 

 

Always Updated

Information on HCV Treatment According to Genotype & More

2005 Index of all Genotype Research


2004 Thru 2001 Index of all Genotype Research 

 

 

 

   

         

 
HOME Liver Cancer
FAQ Great Place To Start Autoimmune Hepatitis
Have You Just Been Diagnosed ? Other Medical Conditions & HCV
Glossary HCV Worldwide News & Research
History Of HCV HCV News Archives 2001-2002
Your Liver Functions Internet Conference Reports on All New and Current HCV Therapies
Symptoms Of HCV Nutrition & HCV
Transmission Of HCV Interviews: Members & Professionals
Sex And HCV HCV Support Groups Listed By State
Understanding Your Blood Tests  Labs Transplant Support Groups Listed By State
Monitoring Blood Work On Treatment Insurance, Financial Aid & Free Meds
Liver Biopsy Understanding Your Results How to Find a Doctor & What to Ask
Viral Loads Members Share Their First Shot Experience
Genotypes Shared Stories From Our  Members
Infergen Your Questions & HCV
 Inhibitors &  New Therapies Chat Room & Message Boards
Peg Intron & Pegasys Books On HCV
Help With Side Effects During Treatment Food For The Soul Inspirational Stories
Drug Interactions & Treatment Informative Links
Latest HCV Trials Pictures Of Our Members
Liver Fibrosis What's New at Janis and Friends
Cirrhosis Sign Our Guestbook
Transplants Contact Us mailto:JansDream@angelhaven.com
Current Transplant Research In Memory Of Janis

 Page Reviewed Aug 4 2005